JAFRAL CEO Dr. Frenk Smrekar to Attend AMR Conference in Basel

JAFRAL is pleased to share that our CEO, Dr. Frenk Smrekar, will be present at the upcoming AMR Conference in Basel.

As antimicrobial resistance (AMR) continues to be one of the most pressing global health challenges, Dr. Smrekar looks forward to engaging with participants and discussing how phage therapy can play a key role in addressing this issue.

The conference provides an important platform for collaboration among industry leaders, policymakers, and researchers, and JAFRAL is proud to contribute to the dialogue on innovative solutions for combating AMR.